-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-103 in T-Cell Acute Lymphocytic Leukemia (T-Cell Acute Lymphoblastic Leukaemia) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-103 in T-Cell Acute Lymphocytic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-010 in Follicular Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in Follicular Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-010 in Follicular Lymphoma Drug Details: CB-010 is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-010 in Mantle Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in Mantle Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-010 in Mantle Cell Lymphoma Drug Details: CB-010 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-010 in Diffuse Large B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in Diffuse Large B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-010 in Diffuse Large B-Cell Lymphoma Drug Details: CB-010 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-010 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-010 in Primary Mediastinal B-Cell Lymphoma Drug Details: CB-010 is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-010 in B-Cell Non-Hodgkin Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-010 in B-Cell Non-Hodgkin Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-010 in B-Cell Non-Hodgkin Lymphoma Drug Details: CB-010 is under development...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – CB-307 in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - CB-307 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. CB-307 in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Drug Details:...
-
Product Insights
CB – Culemborg Warehouse – Gelderland
The CB – Culemborg Warehouse – Gelderland project involves the construction of a 10,000m2 warehouse on Erasmusweg 5 in Culemborg, Gelderland, the Netherlands. Equip yourself with the essential tools needed to make informed and profitable decisions with our CB – Culemborg Warehouse – Gelderland report. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business days of the purchase, excluding weekends and holidays. Certain sections of the report...
-
Sector Analysis
NewCroatia Construction Market Size, Trend Analysis by Sector, Competitive Landscape and Forecast to 2028
Croatia’s construction industry is expected to grow by 4.4% in real terms in 2024, supported by an increase in the total construction permits issued, and the government’s investment in transport infrastructure projects. According to the Croatian Bureau of Statistics (CBS), the construction industry's value add grew by 8.4% year on year (YoY) in Q4 2023, preceded by Y-o-Y growth of 4.8% in Q3 and 0.9% in Q2 2023. In addition, the CBS reported that the value of new construction orders...